If you’ve tuned into a podcast lately, chances are you’ve noticed that advertising formats have changed a little bit. Maybe you listened to the host give a heartfelt update about needing new revenue streams to keep the show going. Or maybe you noticed a few more ads than usual – some of which weren’t even…

Gram-negative bacteria. The very name can send shivers down the spines of healthcare professionals. These microorganisms, characterized by their complex cell wall structure, are increasingly developing resistance to even our strongest antibiotics.  If bacterial infections in general are a concern, gram-negative bacteria are particularly challenging – since even minor infections can become life-threatening when they…

Unlock unparalleled commercial success with PurpleLab®’s cutting-edge data analytics and real-world insights.

The healthcare landscape is more complex than ever – and pharmaceutical companies are feeling the pressure. From pre-commercial drug development to post-launch performance, success hinges on a deep understanding of the full patient journey. However, traditional approaches to patient mapping often miss the nuanced factors that shape real-world health outcomes. Enter real-world data (RWD) enriched…

Cancer survival rates have improved dramatically over the past few decades thanks to ongoing advances in therapeutics. As research continues to push the boundaries of medicine, two innovative technologies stand out in the fight against cancer: Antibody-Drug Conjugates (ADCs) and PROteolysis TArgeting Chimeras (PROTACs). These cutting-edge approaches are refining how we treat cancer and opening…

For all the buzz around the Inflation Reduction Act (IRA), opinions on its impact are sharply divided – especially in the life sciences sector. Critics argue that the IRA’s drug pricing provisions, particularly Medicare price negotiation, will stifle innovation by reducing incentives for pharmaceutical companies to invest in research and development.  But these concerns don’t…

Nurse Practitioners (NPs) and Physician Assistants (PAs) are no longer just “support” staff for physicians. These clinicians are now taking on much bigger roles in patient care, including the ability to prescribe medications without physician oversight.  The COVID-19 pandemic accelerated the already growing trend of expanding NPs’ and PAs’ scope of practice. Now, five years…

Mapping the patient journey has become more complex, but also more critical to understand what is actually happening in the treatment or therapeutic landscape. This webinar will explore how leveraging PurpleLab’s integrated data sources, including claims and Social Determinants of Health (SDOH), can unlock critical insights for commercial, market access, and medical affairs teams.

Learn more about what PurpleLab can do for Clinical Trials Life Sciences Download